ArticlemBio2021

The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.

Kun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.